Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dietlein

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2009
FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive valueJ Markova, C Kobe, M Skopalova, et al.
Nuklearmedizin. Nuclear Medicine|February 19, 2008
99mTc-MIBI SPECT in primary hyperparathyroidism. Influence of concomitant vitamin D deficiency for visualization of parathyroid adenomasM Schmidt, N Thoma, M Dietlein, et al.
Nuklearmedizin. Nuclear Medicine|October 17, 2007
[Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3)]M Dietlein, J Dressler, W Eschner, et al.
Nuklearmedizin. Nuclear Medicine|June 13, 2003
[Guideline for in vivo- and in vitro procedures for thyroid diseases (version 2)]M Dietlein, J Dressler, F Grünwald, et al.
Blood|November 8, 2001
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin diseaseM R Weihrauch, D Re, K Scheidhauer, et al.
European Journal of Nuclear Medicine|November 10, 2001
Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre studyM Diehl, J H Risse, K Brandt-Mainz, et al.
Nuklearmedizin. Nuclear Medicine|February 26, 2003
[Hodgkin's lymphoma in nuclear medicine: diagnostic and therapeutic aspects]J O Staak, M Dietlein, A Engert, et al.
Journal of Surgical Oncology|July 22, 2010
[18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancerD Vallböhmer, A H Hölscher, P M Schneider, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2010
Evaluation of interim PET response criteria in paediatric Hodgkin's lymphoma--results for dedicated assessment criteria in a blinded dual-centre readC Furth, H Amthauer, H Hautzel, et al.
European Journal of Nuclear Medicine|January 19, 2000
Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre studyF Grünwald, T Kälicke, U Feine, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2009
FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive valueJ Markova, C Kobe, M Skopalova, et al.
Nuklearmedizin. Nuclear Medicine|February 19, 2008
99mTc-MIBI SPECT in primary hyperparathyroidism. Influence of concomitant vitamin D deficiency for visualization of parathyroid adenomasM Schmidt, N Thoma, M Dietlein, et al.
Nuklearmedizin. Nuclear Medicine|October 17, 2007
[Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3)]M Dietlein, J Dressler, W Eschner, et al.
Nuklearmedizin. Nuclear Medicine|June 13, 2003
[Guideline for in vivo- and in vitro procedures for thyroid diseases (version 2)]M Dietlein, J Dressler, F Grünwald, et al.
Blood|November 8, 2001
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin diseaseM R Weihrauch, D Re, K Scheidhauer, et al.
European Journal of Nuclear Medicine|November 10, 2001
Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre studyM Diehl, J H Risse, K Brandt-Mainz, et al.
Nuklearmedizin. Nuclear Medicine|February 26, 2003
[Hodgkin's lymphoma in nuclear medicine: diagnostic and therapeutic aspects]J O Staak, M Dietlein, A Engert, et al.
Journal of Surgical Oncology|July 22, 2010
[18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancerD Vallböhmer, A H Hölscher, P M Schneider, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2010
Evaluation of interim PET response criteria in paediatric Hodgkin's lymphoma--results for dedicated assessment criteria in a blinded dual-centre readC Furth, H Amthauer, H Hautzel, et al.
European Journal of Nuclear Medicine|January 19, 2000
Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre studyF Grünwald, T Kälicke, U Feine, et al.
Pageof 13